Statements (51)
Predicate | Object |
---|---|
gptkbp:instanceOf |
fatty acid amide
endogenous compound |
gptkbp:actsOn |
gptkb:CB1_receptor
gptkb:CB2_receptor gptkb:GPR119 GPR55 peroxisome proliferator-activated receptor alpha (PPAR-α) |
gptkbp:CASNumber |
544-31-0
|
gptkbp:category |
dietary supplement
nutraceutical lipid mediator endocannabinoid-like molecule |
gptkbp:chemicalFormula |
C18H37NO2
|
gptkbp:discoveredBy |
gptkb:Rita_Levi-Montalcini
|
gptkbp:effect |
analgesic
anti-inflammatory neuroprotective |
gptkbp:firstDescribed |
1957
|
gptkbp:foundIn |
garlic
corn soybeans peanuts soybean oil alfalfa egg yolk lupin oat soy lecithin peanut oil |
https://www.w3.org/2000/01/rdf-schema#label |
palmitoylethanolamide
|
gptkbp:IUPACName |
N-(2-hydroxyethyl)hexadecanamide
|
gptkbp:metabolism |
N-acylethanolamine acid amidase (NAAA)
fatty acid amide hydrolase (FAAH) |
gptkbp:molecularWeight |
299.49 g/mol
|
gptkbp:notScheduled |
gptkb:United_States
|
gptkbp:relatedTo |
gptkb:anandamide
oleoylethanolamide |
gptkbp:routeOfAdministration |
oral
topical sublingual |
gptkbp:usedFor |
gptkb:carpal_tunnel_syndrome
osteoarthritis multiple sclerosis peripheral neuropathy chronic pain respiratory infections fibromyalgia inflammatory disorders interstitial cystitis |
gptkbp:bfsParent |
gptkb:fatty_acid_amide_hydrolase
|
gptkbp:bfsLayer |
7
|